The WannaCry ransomware attack that successfully targeted Merck is not the only cyberattack to which the pharmaceutical industry has fallen victim. As pharmaceutical and biotechnology companies move toward greater digitalization and the storage of more valuable data, their digital security practices become more and more critical.